3189 results for «306»

Filter By

3189 results

Valve-in-valve TAVI

21 May 2025 – From EuroPCR 2025

Explore valve-in-valve TAVI strategies for patients with degenerated surgical valves, focusing on small aortic annuli. This session covers the impact of valve design and implant techniques, valve fracturing methods, procedural outcomes of repeat TAVI, and mid-to-long-term results from the ACCURATE NEO 2 study.

Valve-in-valve TAVI

AsiaPCR/SingLIVE 2017: closing Ceremony and Awards

21 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....

Prof. Tian-Hai Koh

Chairperson

Tian Hai Koh
Rosli Mohd Ali

Chairperson

Mohd Ali Rosli
AsiaPCR/SingLIVE 2017:

AsiaPCR/SingLIVE 2017: Opening Ceremony

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.

Upendra Kaul

Chairperson

Upendra Kaul
AsiaPCR/SingLIVE 2017:

Opening Ceremony: PCR London Valves 2018

10 Sep 2018 – From PCR London Valves 2018

Join J. J. Bax, B. Prendergast and J. Fajadet for the opening ceremony of PCR London Valves 2018 and find out more about the global challenge of the increasing burden of heart disease and the new technologies for the treatment of SHD.

Opening Ceremony: PCR London Valves 2018

Closing Ceremony and Highlights of the Course: PCR London Valves 2018

11 Sep 2018 – From PCR London Valves 2018

Join B. Prendergast for the closing ceremony of PCR London Valves 2018 and discover the course highlights!

Closing Ceremony and Highlights of the Course: PCR London Valves 2018

Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial

28 Mar 2026

During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).

Luigi Biasco

Author

Luigi Biasco
CHAMPION-AF: LAAC vs oral anticoagulation in atrial fibrillation

Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study

19 Sep 2022

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Pamela Gatto

Author

Pamela Gatto
Updates from the Intrepid Pilot Study: Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement

How to perform angiographic check after large-sheath removal in single access procedures

18 Mar 2024

In the absence of other arterial access, this step-by-step tutorial shows how to perform anterograde angiography of the arterial axis after removal of the large sheath, making it easier to recognise and rapidly manage vascular complications such as arterial lesions and haemostasis failure.

Francesco Burzotta

Author

Francesco Burzotta
Lazzaro Paraggio

Author

Lazzaro Paraggio
Mattia Lunardi

Author

Mattia Lunardi
Cristina Aurigemma

Author

Cristina Aurigemma
Enrico Romagnoli

Author

Enrico Romagnoli

Author

Francesco Fracassi

Author

Antonino Buffon
C. Trani

Author

Carlo Trani
How to perform angiographic check after large-sheath removal in single access procedures

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
Didn’t find what you were looking for?